PCL Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
31
- Stock Symbol
-
241820
- Share Price
-
$4.63
- (As of Wednesday Closing)
PCL General Information
Description
PCL Inc is engaged in the development of vitro diagnostics products by SG Cap technology used in immobilizing disease biomarkers. It offers blood testing kit, multiplex antigen detection kits, and ultra-low volume non-contact liquid handling.In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified.
Contact Information
Website
pclchip.comCorporate Office
- Room 701, Star Valley
- 99, Digital-ro 9-gil, Geumcheon-gu
- Seoul, 08510
- South Korea
Corporate Office
- Room 701, Star Valley
- 99, Digital-ro 9-gil, Geumcheon-gu
- Seoul, 08510
- South Korea
PCL Timeline
PCL Stock Performance
As of 10-Sep-2025, PCL’s stock price is $4.63.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.63 | $4.37 | $4.30 - $21.24 | 2.78M | 5.58K | -$13.06 |
PCL Financials Summary
As of 30-Sep-2025, PCL has a trailing 12-month revenue of $3.53M.
|
In Thousands, USD |
TTM 30-Sep-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 26,379 | 147,640 | 137,159 | |
| Revenue | 3,534 | 913 | 6,447 | 28,803 |
| EBITDA | (33,001) | (36,387) | (11,983) | 1,103 |
| Net Income | (33,375) | (38,359) | (15,540) | (3,109) |
| Total Assets | 12,197 | 14,648 | 48,262 | 69,631 |
| Total Debt | 6,229 | 7,460 | 14,749 | 24,691 |
PCL Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PCL Patents
PCL Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022164214-A1 | Apparatus and method for detecting spots within diagnostic kit result image | Inactive | 28-Jan-2021 | ||
| WO-2022164215-A1 | Device and method for diagnostic test using exclusion of atypical foreign material from test result image of artificial intelligence-based diagnostic kit | Inactive | 28-Jan-2021 | ||
| JP-7650538-B2 | A novel biomarker for diagnosing alzheimer's disease discovered from blood-derived exosomes and a method for diagnosing alzheimer's disease using the same | Active | 30-Nov-2020 | ||
| JP-2023551327-A | Novel alzheimer's disease diagnostic biomarker discovered from blood-derived exosomes and alzheimer's disease diagnostic method using the same | Active | 30-Nov-2020 | ||
| DE-112021006226-T5 | Novel biomarker for diagnosing alzheimer's disease discovered in a blood-derived exosome and method for diagnosing alzheimer's disease using the same | Inactive | 30-Nov-2020 | G01N33/6896 |
PCL Signals
PCL Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PCL ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Technology Hardware
Industry
Rank
Percentile
Electronics Equipment
Subindustry
Rank
Percentile
PCL FAQs
-
When was PCL founded?
PCL was founded in 2008.
-
Where is PCL headquartered?
PCL is headquartered in Seoul, South Korea.
-
What is the size of PCL?
PCL has 31 total employees.
-
What industry is PCL in?
PCL’s primary industry is Other Healthcare Technology Systems.
-
Is PCL a private or public company?
PCL is a Public company.
-
What is PCL’s stock symbol?
The ticker symbol for PCL is 241820.
-
What is the current stock price of PCL?
As of 10-Sep-2025 the stock price of PCL is $4.63.
-
What is PCL’s current revenue?
The trailing twelve month revenue for PCL is $3.53M.
-
What is PCL’s annual earnings per share (EPS)?
PCL’s EPS for 12 months was -$13.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process